Non-invasive Treatment for Long COVID (Post COVID-19 Condition) Brain Fog
ConditionLong COVID
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMayo Clinic
About this trial
This study aims to assess the effects of both acute and chronic exposures to hypoxia and hypercapnia in patients with Long COVID syndrome.
Eligibility criteria
Qualifiers
English speaking
Diagnosis of Long COVID
Disqualifiers
Coronary artery dissection or aortic dissection
Neurological disease (e.g. dementia, Alzheimer's disease, or other brain-related disease)
Cerebrovascular disease or stroke
Aneurysm
Trial design
Treatments tested in this trial
- Acute Placebo Visit
- Acute Progressive Carbon Dioxide
- Acute Intermittent Hypoxia
- Training: Progressive Carbon Dioxide Ramping
- Training: Intermittent Hypoxic Exposure
- Training: Placebo Control
Treatment groups
45 Participants
are divided into 8 treatment groups8
Treatment groupsSee each treatment group below.
Sponsors and collaborators
Source ClinicalTrials.gov